ARTIAM BIO
Artiam Bio is a biotechnology business focused on the development of second-generation type 1 cannabinoid receptor (CB1) antagonists for the treatment of serious disorders.
ARTIAM BIO
Social Links:
Industry:
Biotechnology Health Care
Founded:
2020-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.artiambio.net
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
70.71 K USD
Technology used in webpage:
Euro SingleHop
Similar Organizations
Biomeme
Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
KinaRx
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Symvivo Corporation
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.
Investors List
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Artiam Bio
Official Site Inspections
http://www.artiambio.net
- Host name: chi202.greengeeks.net
- IP address: 184.154.70.198
- Location: Chicago United States
- Latitude: 41.8777
- Longitude: -87.6376
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60604
More informations about "Artiam Bio"
Type 1 cannabinoid receptor (CB1) antagonists | Artiam โฆ
Artiam Bio, Inc. is a biotechnology company developing refined type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases. See details»
Artiam Bio - Crunchbase Company Profile & Funding
Artiam Bio is a biotechnology focused on the development of second-generation type 1 cannabinoid receptor antagonists for the treatment. See details»
ARTIAM BIO INC. | SBIR.gov
Company Information Address 307 Stromer Dr Cary, NC27513-2754 United States https://www.artiambio.net Information UEI: FKJAXBQEDUJ8 # of Employees: 2 Ownership โฆ See details»
Artiam Bio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Artiam Bio. Use the PitchBook Platform to explore the full profile. See details»
ARTIAM BIO INC. - VentureRadar
Artiam Bio, Inc. is a biotechnology company that is developing refined type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases. We are accelerating innovation to bring safe โฆ See details»
Artiam Bio Inc. Information - RocketReach
Artiam Bio Inc. is a Biotechnology Research company located in Morrisville, North Carolina with 1 employees. Find top employees, contact details and business statistics at RocketReach. See details»
Artiam Bio Inc | www.inknowvation.com
Location Information PO Box 624 Morrisville, NC 27560 (919) 452-385 N/A www.artiambio.net Location: SingleCongr. District: 02County: Wake See details»
Artiam Bio - Products, Competitors, Financials, Employees, โฆ
Artiam Bio Unclaimed artiambio.net Overview & Products Financials People Founded Year 2020 Stage Grant | Alive See details»
Artiam Bio Inc. on LinkedIn: NCBiotech Awards $1.7 Million in โฆ
Artiam Bio is developing ARTM-194 for #CUD, which is a major area of need with support from #NIH and #NIDA. Learn more at artiambio.net See details»
Artiam Bio Inc. | North Carolina Biotech Center
Artiam Bio is targeting the endocannabinoid system to treat diseases using pharmacology and medicinal chemistry approaches. Artiam Bio is initially focused on non-alcoholic and alcoholic โฆ See details»
Contact - Artiam Bio
Contact Artiam Bio to learn about our type 1 cannabinoid receptor (CB1) technology targeting non-alcoholic steatohepatitis, Prader Willi Syndrome & Cannabis Use Disorder. See details»
Artiam Bio Inc. Overview | SignalHire Company Profile
Artiam Bio, Inc. is a biotechnology company that is developing second generation type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases. We are accelerating โฆ See details»
Artiam Bio Inc. | LinkedIn
Sitio web artiambio.net Sector Biotecnología Tamaño de la empresa De 2 a 10 empleados Sede Morrisville, North Carolina Tipo De financiación privada Fundación 2020 See details»
Artiam Bio Profile - highergov.com
Federal grant recipient ARTIAM BIO INC. (UEI FKJAXBQEDUJ8, CAGE 8N0F0) is headquartered in Cary NC. Its primary registered NAICS is 541715 Research and Development in the โฆ See details»
Artiam Bio | Liver Disease | Cannabis Use Disorders
Artiam Bio is Pioneering CB1 Therapeutics Using innovative science, passion and persistence, Artiam Bio is developing novel compounds and sophisticated strategies, for targeting the CB1 โฆ See details»
Artiam Bio - Updates, News, Events, Signals & Triggers
Artiam Bio is a biotechnology focused on the development of second-generation type 1 cannabinoid receptor antagonists for the treatment. See details»
Targeted Solutions: CB1 Receptor Antagonists | Artiam Bio
Dysregulated endocannabinoid signaling can lead to several diseases. Past attempts to leverage the benefits of CB1 receptor antagonists produced adverse effects in certain groups of โฆ See details»
Treatment for cannabis use disorder | SBIR.gov
Abstract Our goal is to develop an innovative pharmacotherapy for cannabis use disorder (CUD) that affects over 4 million Americans. We propose to develop a novel second generation โฆ See details»
ARTIAM BIO INC. - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
็ง่ฅๅ ฌๅธ| 2020| United States | artiambio.net ็ง่ฅๅ ฌๅธ| 2020| United States | artiambio.net ๆดๆฐไบ๏ผ2024-02-22 ๆฆ่ง ็ฎก็บฟๅธๅฑ ่ฏ็ฉไบคๆ ่ฅๆถ ็ง็ ๅบ้ (NIH) ๆ่ต ่่ต See details»
Cannabinoid CB1 Receptor Blockade Indications | Artiam Bio
Cannabinoid CB1 Receptor Blockades indications include NASH/NAFLD Liver Disease, Cannabis Use Disorders & Prader-Willi Syndrome. See details»